Ledeninformatie
Pr Francesco Testa
Italië
Team
Pr Francesca Simonelli
Italië
Dr Raffaella Brunetti Pierri
Italië
Dr Valentina Di Iorio
Italië
HCP-centrum
contact
AOU Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy
Klinische proeven
Natural history of patients with inherited retinal diseases due to mutations in RPE65 gene
An Open-Label, Dose Escalation and Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Tolerability of Sepofarsen in Pediatric Subjects G (p.Cys998X) Mutation.
Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Clinical and Molecular Studies in Families With Inherited Eye Disease
Safety and Efficacy of Emixustat in Stargardt Disease.
Natural History Study in Subjects With Usher Syndrome.
A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura™ (Complement C5 Inhibitor) Compared to Sham in Subjects With Autosomal Recessive Stargardt Disease
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration